[ET Net News Agency, 30 October 2024] REMEGEN (09995) rose 10.1% to HK$15.9, breaking
above the 10-D SMA of HK$14.802.
It hits an intra-day high of HK$15.94, and an intra-day low of HK$14.44. The total
shares traded was 2.16 million, with a value of HK$33.17m. The active buy/sell ratio is
73:27, with net buying turnover of HK$14.65m. HSBC BROKING SEC (HK) accounts for greatest
net responsive buying turnover of HK$629,150, with volume weighted average price of
HK$15.729. CHINA INV INFO accounts for greatest net responsive selling turnover of
HK$2.7m, with volume weighted average price of HK$15.323. The stock has risen a combined
11.2% over the past 3 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 15.900 % Chg +10.11%
High 15.940 Low 14.440
Shares Tr 2.16m Turnover 33.17m
10-D SMA 14.802 %H.V 132.892
20-D SMA 15.977 VWAP 15.346
50-D SMA 13.981 RSI14 55.056
----------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 73:27, with net buying
turnover of HK$14.65m, rising a combined 11.2% over the past 3 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 15.90 +10.11
IMMUNEONCO-B (01541) 7.60 +4.11
INNOVENT BIO (01801) 36.00 -3.10
JXR (01951) 3.52 Unchanged
EVEREST MED-B (01952) 31.00 +0.49
WUXI BIO (02269) 17.06 -0.12
TIGERMED (03347) 36.65 -7.80
BEIGENE (06160) 127.70 -2.74
CANSINOBIO (06185) 29.65 +13.17
AIM VACCINE (06660) 7.50 +4.46
---------------------------------------------
(ed)